PTHrP might be used in obesity treatment and its complications for its ability to reprogram adipogenesis and adipose tissue expansion, WAT browning and for the improvement of the insulin sensitivity. This evidence concerns the gene PTHLH and obesity due to melanocortin 4 receptor deficiency.